MUSC spinoff company touts better, safer cancer therapy but faces tough investment climate

Researchers at MUSC are using the immune system to fight cancer, and doing it safer, cheaper, and with a longer-lasting effect. A Mount Pleasant company is pushing that technology but is up against a bad business environment.